TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ADAG

Adagene Inc

Healthcare · Biotechnology

3.20$ +9.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ADAG
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– +94.6% -20.4% +124.9% -19.6% -24.1% -22.9% -12.3%
– +100.6% -23.9% +135.1% -19.7% -24.0% -22.6% -11.9%
– +476.2% -18.8% +132.1% -17.6% -23.5% -22.5% -12.5%
– +104.9% -25.2% +132.1% -17.6% -23.5% -22.5% -12.5%
– +49.7% -93.8% +5,569.9% -91.7% -64.2% -96.3% +108.8%
– – – – – – – –
– -26.3% +10.0% +68.7% -14.7% – – –
– +70.7% +6.6% -81.0% +110.3% -34.8% -14.2% +10.8%
– -30.6% +124.8% +84.7% +84.7% -42.9% +21.4% -34.1%
– -55.4% +382.6% -10.3% +206.2% -37.6% +108.7% -71.7%
– +27.5% +154.0% +83.5% +10.4% -15.6% +37.1% -32.0%
– – +95.6% +0.9% +372.8% -4.3% -96.9% +172.7%
– – – – -46.9% -15.1% -28.4% -30.0%
– – – – – – – –
– +264.1% -20.6% +14.1% +8.2% +1.1% +2.8% +4.8%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?